{"id":181844,"date":"2025-11-15T10:04:08","date_gmt":"2025-11-15T10:04:08","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/181844\/"},"modified":"2025-11-15T10:04:08","modified_gmt":"2025-11-15T10:04:08","slug":"ai-bubble-fear-this-sector-is-quietly-surging-while-tech-sinks-amgen-nasdaqamgn-bristol-myers-squibb-nysebmy","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/181844\/","title":{"rendered":"AI Bubble Fear? This Sector Is Quietly Surging While Tech Sinks – Amgen (NASDAQ:AMGN), Bristol-Myers Squibb (NYSE:BMY)"},"content":{"rendered":"

It hasn’t been an easy stretch for technology and AI stocks, with triple-digit year-to-date gainers like Palantir Technologies Inc. <\/strong>(NASDAQ:<\/a>PLTR<\/a>) and CoreWeave Inc.<\/strong> (NASDAQ:<\/a>CRWV<\/a>) facing steep corrections\u2014but in the shadow of this turmoil, another sector is quietly rising, delivering both resilience and returns that few on Wall Street saw coming.<\/p>\n

While the Nasdaq 100 is on pace for its worst November since 2008, healthcare equities are showing remarkable strength. <\/p>\n

The Healthcare Select Sector SPDR Fund <\/strong>(NYSE:<\/a>XLV<\/a>) is up nearly 6% month-to-date, its best monthly performance since January and the top-performing sector in the S&P 500 for November so far.<\/p>\n

By contrast, the Technology Select Sector SPDR Fund <\/strong>(NYSE:<\/a>XLK<\/a>) has shed more than 5% this month, dragged lower by sharp declines in artificial intelligence-linked names as concerns mount over supply constraints and valuation excesses.<\/p>\n

This divergence is now shaping up to be one of the largest monthly outperformance gaps between healthcare and tech since 2002, according to historical ETF return data.<\/p>\n

Chart: Healthcare Stocks Battle For Best Month Versus Tech Since 2002Follow The Flows: Biggest Healthcare Inflows Since Jan 2021 <\/p>\n

Investor flows are confirming the rotation. According to Bank of America’s latest Flow Show report, compiled by the bank\u2019s chief investment strategist Michael<\/strong> Hartnett<\/strong>, healthcare just recorded its largest weekly inflow since January 2021. <\/p>\n

In a market environment defined by uncertainty, high valuations, and cooling rate-cut bets, investors are increasingly treating healthcare as a defensive haven, the place to be when things unravel elsewhere. <\/p>\n

Valuations Matter: Tech Expensive, Healthcare Still Cheap<\/p>\n

Part of the renewed appeal in healthcare is driven by valuation. <\/p>\n

Despite this week’s tech pullback, technology stocks still trade at rich multiples. <\/p>\n

The S&P 500<\/strong>, tracked by the Vanguard S&P 500 ETF (NYSE:<\/a>VOO<\/a>)<\/strong>, currently trades at a forward P\/E ratio of 23x, but the XLK sits even higher at around 30x.<\/p>\n

In contrast, the XLV trades at 20x forward earnings, making healthcare one of the cheapest sectors in the market, alongside financials, utilities and energy.<\/p>\n

This valuation gap offers a compelling hedge. If rates do not fall as predicted or inflation makes a comeback, expensive growth stocks could remain under pressure, while sectors with strong cash flows, stable margins, and lower multiples\u2014like healthcare\u2014may see continued investor interest. <\/p>\n

Top-Performing Healthcare Stocks<\/strong> In November 2025<\/p>\nStock Name<\/strong>MTD % Change (Nov. 1\u201314)<\/strong><\/tr>\n\nEli Lilly and Co. (NYSE:LLY<\/a>)<\/strong><\/td>\n+19.62%<\/td>\n<\/tr>\n\nHenry Schein Inc. (NASDAQ:HSIC<\/a>)<\/strong><\/td>\n+13.88%<\/td>\n<\/tr>\n\nAmgen Inc. (NASDAQ:AMGN<\/a>)<\/strong><\/td>\n+13.51%<\/td>\n<\/tr>\n\nIncyte Corp. (NASDAQ:INCY<\/a>)<\/strong><\/td>\n+13.35%<\/td>\n<\/tr>\n\nThe Cigna Group (NYSE:CI<\/a>)<\/strong><\/td>\n+10.85%<\/td>\n<\/tr>\n\nSTERIS plc (NYSE:STE<\/a>)<\/strong><\/td>\n+10.41%<\/td>\n<\/tr>\n\nIDEXX Laboratories Inc. (NASDAQ:IDXX<\/a>)<\/strong><\/td>\n+10.20%<\/td>\n<\/tr>\n

Now Read<\/strong>: <\/p>\n

Image by Lightspring via Shutterstock<\/p>\n","protected":false},"excerpt":{"rendered":"It hasn’t been an easy stretch for technology and AI stocks, with triple-digit year-to-date gainers like Palantir Technologies…\n","protected":false},"author":2,"featured_media":181845,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[41780,5325,41781,10751,19553,62721,5329,9505,5324,18,135,475,474,19,17,5323,102666,102667,102668,102669,102670,102671,102672,41194,62729,37515,19556,102673,102674,102675,62732,5354,31481,5355],"class_list":{"0":"post-181844","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-category-econ-s","9":"tag-category-equities","10":"tag-category-etfs","11":"tag-category-health-care","12":"tag-category-large-cap","13":"tag-category-sector-etfs","14":"tag-category-tech","15":"tag-category-top-stories","16":"tag-cms-wordpress","17":"tag-eire","18":"tag-health","19":"tag-health-care","20":"tag-healthcare","21":"tag-ie","22":"tag-ireland","23":"tag-pageisbzpro-bz","24":"tag-symbol-amgn","25":"tag-symbol-bmy","26":"tag-symbol-ci","27":"tag-symbol-crwv","28":"tag-symbol-hsic","29":"tag-symbol-idxx","30":"tag-symbol-incy","31":"tag-symbol-lly","32":"tag-symbol-pfe","33":"tag-symbol-pltr","34":"tag-symbol-regn","35":"tag-symbol-ste","36":"tag-symbol-voo","37":"tag-symbol-xlk","38":"tag-symbol-xlv","39":"tag-tag-consumer-tech","40":"tag-tag-expert-ideas","41":"tag-tag-stories-that-matter"},"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/181844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=181844"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/181844\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/181845"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=181844"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=181844"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=181844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}